Overview

First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
First-in-Patient Study for sing le dose of M201-A hydrochloride injection in Japanese patients with paroxysmal atrial fibrillation.
Phase:
Phase 2
Details
Lead Sponsor:
Kitasato University
Collaborators:
Aetas Pharma Co. Ltd.
Aetas Pharma Co., Ltd.